SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
China SXT Pharmaceuticals, Inc.
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026
$0.11+0.05 (+71.08%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
China SXT Pharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements China SXT Pharmaceuticals filed with the SEC
PRESS RELEASE DATED OCTOBER 8, 2026
EX-99.1 to Form 6-K
PRESS RELEASE DATED JULY 23, 2026
EX-99.1 to Form 6-K
PRESS RELEASE DATED JANUARY 9, 2026
EX-99.1 to Form 6-K
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2025
EX-99.2 to Form 6-K
FORM OF PROXY CARD TO BE MAILED TO THE SHAREHOLDERS OF THE COMPANY
EX-99.2 to Form 6-K
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2024
EX-99.2 to Form 6-K
WARRANT EXCHANGE AGREEMENT DATED MARCH 13, 2025
EX-99.1 to Form 6-K
SECURITIES PURCHASE AGREEMENT DATED JANUARY 21, 2025
EX-99.1 to Form 6-K
ORDINARY SHARE PURCHASE WARRANT DATED JANUARY 21, 2025
EX-99.2 to Form 6-K
SURRENDER LETTER DATED JANUARY 21, 2025
EX-99.3 to Form 6-K
FORM OF THE EMPLOYMENT AGREEMENT
EX-99.1 to Form 6-K
FORM OF THE DIRECTOR OFFER LETTER
EX-99.2 to Form 6-K
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2023
EX-99.2 to Form 6-K
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2022
EX-99.2 to Form 6-K
FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2021
EX-99.1 to Form 6-K